🇺🇸 FDA
Patent

US 6979671

Cyclosporins for the treatment of immune disorders

expired A61KA61K38/00

Quick answer

US patent 6979671 (Cyclosporins for the treatment of immune disorders) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00